(1)
Sadighi, S. The Challenging Decision to Commence Neoadjuvant Chemotherapy for Hormone-Receptor-Positive Breast Cancer: NAC Hormone-Positive Breast Cancer. Arch Breast Cancer 2024, 11, 106-107.